Evolution of the Average Target: Erasca, Inc.

Evolution of the Target Price: Erasca, Inc.

Changes in Analyst Recommendations: Erasca, Inc.

0856f9b5659c0a25f43.0jSAS17RL20Lpm4QNsaPPxg6K7vgOyq0vlyEgyPJyYk.gljMIGu6QwFG7T5yf4_fcCplc_OWXULA9Bi2zFajnP2dGdYPb71wAl3OAQ~4e3baccbfad6eba200db120949f7601a
06-04 Erasca Shares Rise After BofA Upgrade MT
06-04 Erasca Sees More Balanced Outlook as Early RAS Data Support Clinical Activity, BofA Says MT
06-04 BofA Securities Upgrades Erasca to Neutral From Underperform, Adjusts Price Target to $16 From $9 MT
04-27 Mizuho Raises Price Target on Erasca to $28 From $19, Keeps Outperform Rating MT
03-13 Mizuho Raises Price Target on Erasca to $19 From $16, Keeps Outperform Rating MT
01-27 Mizuho Raises Price Target on Erasca to $16 From $5, Keeps Outperform Rating MT
01-26 Morgan Stanley Raises Price Target on Erasca to $10 From $4, Keeps Equalweight Rating MT
01-07 Piper Sandler Initiates Erasca at Overweight With $5 Price Target MT
01-06 BofA Adjusts Price Target on Erasca to $2 From $1, Maintains Underperform Rating MT
12-09 Mizuho Raises Price Target on Erasca to $5 From $4, Keeps Outperform Rating MT
25-10-16 Stifel Nicolaus Initiates Coverage on Erasca With Buy Rating, $4 Price Target MT
25-09-03 BofA Securities Downgrades Erasca to Underperform MT
25-08-18 Erasca Shares Fall After Downgrade From Morgan Stanley MT
25-08-18 Morgan Stanley Downgrades Erasca to Equalweight From Overweight, Cuts Price Target to $2 From $4 MT
25-07-28 Mizuho Cuts Price Target on Erasca to $4 From $7, Keeps Outperform Rating MT
25-03-26 Raymond James Initiates Erasca at Outperform With $5 Price Target MT
25-01-07 BofA Securities Upgrades Erasca to Buy From Neutral, Maintains $5 Price Target MT
24-11-18 Jefferies Initiates Erasca at Buy With $6 Price Target MT
24-04-02 Goldman Sachs Adjusts Erasca's Price Target to $7 From $6, Maintains Buy Rating MT
24-03-11 Capital One Initiates Erasca at Overweight Rating With $8 Price Target MT
23-11-28 HC Wainwright Cuts Erasca Price Target to $8 From $10, Maintains Buy Rating MT
23-10-11 HC Wainwright Initiates Erasca at Buy Rating With $10 Price Target MT
23-06-06 Evercore ISI Adjusts Erasca's Price Target to $11 From $20, Keeps Outperform Rating MT
23-06-06 Mizuho Securities Adjusts Erasca Price Target to $8 From $9, Maintains Buy Rating MT
23-05-16 Goldman Sachs Adjusts Price Target on Erasca to $9 From $10, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+14.24%
+17.86%
+7.7%
+32.95%
+12.48%
+46%
+15.74%
-12.16%
+1.07%
+6.95%
Average +14.28%
Weighted average by Cap. +17.07%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
19.17USD
Average target price
22.80USD
Spread / Average Target
+18.94%
High Price Target
30.00USD
Spread / Highest target
+56.49%
Low Price Target
18.00USD
Spread / Lowest Target
-6.10%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

BofA Securities
Mizuho Securities
Morgan Stanley
Piper Sandler
Stifel Nicolaus
Raymond James
Jefferies & Co.
Goldman Sachs
Capital One Securities
HC Wainwright
Evercore ISI
Guggenheim
JPMorgan Chase
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
19.17USD
Average target price
22.80USD
Spread / Average Target
+18.94%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ERAS Stock
  4. Consensus Erasca, Inc.